drugset / Trial / NCT00736983

Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's

NCT00736983

Phase 3 Completed 76 enrolled Foundation for Liver Research
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess whether a combination of ciprofloxacin and adalimumab is more effective than adalimumab alone for the treatment of perianal fistulas in Crohn's disease

Timeline

Start
2008-09
Primary completion
2011-09
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adalimumab Monoclonal antibody 40 mg
Comparator Ciprofloxacin Small molecule 500 mg